{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:18:34Z","timestamp":1794406714171,"version":"4.9.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81000758"],"award-info":[{"award-number":["81000758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Science and Technology Innovation Platform Support Project of Zhongnan Hospital, Wuhan University","award":["PTXM2020008"],"award-info":[{"award-number":["PTXM2020008"]}]},{"name":"Science and Technology Innovation Cultivation Fund of Zhongnan Hospital, Wuhan University","award":["cxpy2017043"],"award-info":[{"award-number":["cxpy2017043"]}]},{"name":"the AbbVie foundation for maternity and child care and Prevention of mother-to-child transmission of HIV\u00b7Chinese Association of STD and AIDS Prevention and Control","award":["PMTCT2017-005, PMTCT201901"],"award-info":[{"award-number":["PMTCT2017-005, PMTCT201901"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The program for the prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV) was launched in 2003 in China, but few studies have been conducted to describe the panorama of PMTCT. We investigated the rate and associated factors of mother-to-child transmission (MTCT) in China from 2004 to 2018.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>HIV-infected pregnant women from two areas in China between 2004 and 2018 were enrolled. Antiretrovirals (ARVs) were provided to the mothers and their babies, and the children were followed and tested for HIV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 857 mothers and their 899 children were enrolled, and the overall MTCT rate was 6.6% (95% CI 5.0\u20138.2). The MTCT rates of nonintervention, only formula feeding (FF), infant prophylaxis (IP)\u2009+\u2009FF, single dosage antiretrovirals (sdARVs)\u2009+\u2009IP\u2009+\u2009FF, zidovudine (AZT) alone+IP\u2009+\u2009FF and prenatal combination antiretroviral therapy (cART)\u2009+\u2009IP\u2009+\u2009FF were 36.4, 9.4, 10.0, 5.7, 3.8 and 0.3%, respectively. The MTCT rate declined over time. No ARVs, CD4 count &lt;\u2009200\/\u03bcL, low birth weight, and breastfeeding were associated with MTCT of HIV. For different ARVs, a higher MTCT rate was observed for AZT alone, sdARVs, and no ARVs compared to cART for pregnant women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although the overall MTCT rate remains relatively high, the real-world effect of prenatal cART+IP\u2009+\u2009FF in China has exerted the same protective effects in high-income countries. With the extension of prenatal cART for pregnant women with HIV, the MTCT rate of HIV has gradually declined in China. However, the coverage of prenatal cART for pregnant women should be further improved. The effect of only post-exposure prophylaxis for infants was limited.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05516-3","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T12:03:12Z","timestamp":1603713792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Preventing mother to child transmission of HIV: lessons learned from China"],"prefix":"10.1186","volume":"20","author":[{"given":"Yu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xien","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0490-5328","authenticated-orcid":false,"given":"Ke","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"5516_CR1","volume-title":"Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment and support for women living with HIV\/AIDS and their children in resource-constrained settings","author":"WHO","year":"2004","unstructured":"WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment and support for women living with HIV\/AIDS and their children in resource-constrained settings. Geneva: World Health Organization; 2004."},{"key":"5516_CR2","volume-title":"Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach","author":"WHO","year":"2010","unstructured":"WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach. Geneva: World Health Organization; 2010."},{"key":"5516_CR3","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach","author":"WHO","year":"2013","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva: World Health Organization; 2013."},{"key":"5516_CR4","volume-title":"On the fast-track to an AIDS free generation","author":"UNAIDS","year":"2016","unstructured":"UNAIDS. On the fast-track to an AIDS free generation. Geneva: Joint United Nations Programme on HIV\/AIDS; 2016."},{"issue":"3","key":"5516_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1086\/427287","volume":"40","author":"European Collaborative Study","year":"2005","unstructured":"European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40(3):458.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5516_CR6","first-page":"527","volume":"64","author":"H Peters","year":"2017","unstructured":"Peters H, Francis K, Sconza R, Horn A, C SP, Tookey PA, et al. UK mother-to-child HIV transmission rates continue to decline: 2012-2014. Clin Infect Dis. 2017;64(4):527\u20138.","journal-title":"Clin Infect Dis"},{"key":"5516_CR7","unstructured":"Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data\u2014United States and 6 dependent areas, 2017. HIV Surveill Suppl Rep 2019. 2019;24(3). https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-supplemental-report-vol-24-3.pdf. Accessed 20 Oct 2020."},{"key":"5516_CR8","volume-title":"UNAIDS data 2019","author":"UNAIDS","year":"2019","unstructured":"UNAIDS. UNAIDS data 2019. Geneva: Joint United Nations Programme on HIV\/AIDS; 2019."},{"key":"5516_CR9","unstructured":"National mother-to-child transmission rate of HIV fell to 5.7% in 2016 [http:\/\/www.nwccw.gov.cn\/2017-12\/04\/content_187271.htm]. Accessed 20 Oct 2020."},{"issue":"1","key":"5516_CR10","first-page":"15","volume":"53","author":"Z Zhou","year":"2010","unstructured":"Zhou Z, Meyers K, Li X, Chen Q, Qian H, Lao Y, et al. Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China. Jaids. 2010;53(1):15\u201322.","journal-title":"Jaids"},{"issue":"1","key":"5516_CR11","doi-asserted-by":"publisher","first-page":"18071","DOI":"10.1038\/s41598-018-36623-6","volume":"8","author":"T Gong","year":"2018","unstructured":"Gong T, Wang H, He X, Liu J, Wu Q, Wang J. Investigation of prevention of mother to child HIV transmission program from 2011 to 2017 in Suzhou, China. Sci Rep. 2018;8(1):18071.","journal-title":"Sci Rep"},{"key":"5516_CR12","volume-title":"Implementation plan for prevention of mother-to-child transmission of HIV (revised)","author":"National Health Commission of the People's Republic of China","year":"2008","unstructured":"National Health Commission of the People's Republic of China. Implementation plan for prevention of mother-to-child transmission of HIV (revised); 2008."},{"key":"5516_CR13","volume-title":"Implementation plan for prevention of mother-to-child transmission of HIV, syphilis and hepatitis B","author":"National Health Commission of the People's Republic of China","year":"2011","unstructured":"National Health Commission of the People's Republic of China. Implementation plan for prevention of mother-to-child transmission of HIV, syphilis and hepatitis B; 2011."},{"key":"5516_CR14","volume-title":"Implementation plan for prevention of mother-to-child transmission of HIV, syphilis and hepatitis B","author":"National Health Commission of the People's Republic of China","year":"2015","unstructured":"National Health Commission of the People's Republic of China. Implementation plan for prevention of mother-to-child transmission of HIV, syphilis and hepatitis B; 2015."},{"issue":"5","key":"5516_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/605123","volume":"200","author":"K Liang","year":"2009","unstructured":"Liang K, Gui X, Zhang YZ, Zhuang K, Meyers K, Ho DD. A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding. J Infect Dis. 2009;200(5):682\u20136.","journal-title":"J Infect Dis"},{"issue":"2","key":"5516_CR16","first-page":"83","volume":"36","author":"Y Dong","year":"2018","unstructured":"Dong Y, Xe G, Tang L, Liu J, Tan Z, Bao Z, et al. Effectiveness and associated factors of prevention for mother-to-child human immunodeficiency virus transmission in 536 human immunodeficiency virus-positive pregnant women in Hubei Province. Chin J Infect Dis. 2018;36(2):83\u20139.","journal-title":"Chin J Infect Dis"},{"issue":"6","key":"5516_CR17","first-page":"401","volume":"6","author":"Chinese Center for Disease Control and Prevention","year":"2016","unstructured":"Chinese Center for Disease Control and Prevention. National guideline for detection of HIV\/AIDS. Chin J Viral Dis. 2016;6(6):401\u201327.","journal-title":"Chin J Viral Dis"},{"issue":"1","key":"5516_CR18","first-page":"10","volume":"15","author":"K Liang","year":"2012","unstructured":"Liang K, Gui X, Zhang YZ, Deng LP, Reziyan S, Yan ZZ, et al. Analysis on mother-to-child transmission after maternal acquired human immunodeficiency virus prenatally or before pregnancy. Chin J Perinat Med. 2012;15(1):10\u20135.","journal-title":"Chin J Perinat Med"},{"issue":"4","key":"5516_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2174\/1570162033485140","volume":"1","author":"C Thorne","year":"2003","unstructured":"Thorne C, Newell ML. Mother-to-child transmission of HIV infection and its prevention. Curr HIV Res. 2003;1(4):447\u201362.","journal-title":"Curr HIV Res"},{"key":"5516_CR20","volume-title":"Global health sector strategy on HIV, 2016-2021","author":"WHO","year":"2016","unstructured":"WHO. Global health sector strategy on HIV, 2016-2021. Geneva: World Health Organization; 2016."},{"issue":"10037","key":"5516_CR21","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1016\/S0140-6736(16)30787-5","volume":"387","author":"M Sidib\u00e9","year":"2016","unstructured":"Sidib\u00e9 M, Singh PK. Thailand eliminates mother-to-child transmission of HIV and syphilis. Lancet. 2016;387(10037):2488\u20139.","journal-title":"Lancet"},{"issue":"5","key":"5516_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","volume":"29","author":"ER Cooper","year":"2002","unstructured":"Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484\u201394.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"5516_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/QAD.0000000000000212","volume":"28","author":"CL Townsend","year":"2014","unstructured":"Townsend CL, Byrne L, Cortina-Borja M, Thorne C, De RA, Lyall H, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. Aids. 2014;28(7):1049\u201357.","journal-title":"Aids"},{"issue":"11","key":"5516_CR24","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/cid\/cix1102","volume":"66","author":"S Arikawa","year":"2018","unstructured":"Arikawa S, Rollins N, Jourdain G, Humphrey J, Kourtis AP, Hoffman I, et al. Contribution of maternal antiretroviral therapy and breastfeeding to 24-month survival in human iImmunodeficiency virus-exposed uninfected children: an individual pooled analysis of African and Asian studies. Clin Infect Dis. 2018;66(11):1668\u201377.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"5516_CR25","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1001\/jama.283.9.1167","volume":"283","author":"R Nduati","year":"2000","unstructured":"Nduati R, John G, Mboringacha D, Richardson B, Overbaugh J, Mwatha A, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. Jama. 2000;283(9):1167\u201374.","journal-title":"Jama"},{"issue":"1","key":"5516_CR26","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/QAI.0000000000001758","volume":"79","author":"E Luoga","year":"2018","unstructured":"Luoga E, Vanobberghen F, Bircher R, Nyuri A, Ntamatungiro AJ, Mnzava D, et al. Brief report: no HIV transmission from virally suppressed mothers during breastfeeding in rural Tanzania. J Acquir Immune Defic Syndr. 2018;79(1):e17\u201320.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10018","key":"5516_CR27","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0140-6736(15)00984-8","volume":"387","author":"N Nagot","year":"2016","unstructured":"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, et al. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016;387(10018):566\u201373.","journal-title":"Lancet"},{"key":"5516_CR28","unstructured":"Paioni P. Discontinuation of neonatal postexposure prophylaxis in infants born to HIV-infected mothers with suppressed plasma viral load: safety and implementation of the new Swiss recommendations. EACS. 2019;2019.\u00a0http:\/\/resourcelibrary.eacs.cyim.com\/mediatheque\/media.aspx?mediaId=78043&playlistId=78018&channel=28172. Accessed 20 Oct 2020."},{"issue":"11","key":"5516_CR29","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1097\/QAD.0000000000001535","volume":"31","author":"CE Kennedy","year":"2017","unstructured":"Kennedy CE, Yeh PT, Pandey S, Betran AP, Narasimhan M. Elective cesarean section for women living with HIV: a systematic review of risks and benefits. Aids. 2017;31(11):1579\u201391.","journal-title":"Aids"},{"key":"5516_CR30","volume-title":"Consolidated guideline on sexual and reproductive health and rights of women living with HIV","author":"WHO","year":"2017","unstructured":"WHO. Consolidated guideline on sexual and reproductive health and rights of women living with HIV. Geneva: World Health Organization; 2017."},{"key":"5516_CR31","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","author":"WHO","year":"2016","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2016."},{"issue":"6","key":"5516_CR32","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1097\/AOG.0b013e3181e00955","volume":"115","author":"GS Birkhead","year":"2010","unstructured":"Birkhead GS, Pulver WP, Warren BL, Hackel S, Rodr\u00edguez D, Smith L. Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002-2006. Obstet Gynecol. 2010;115(6):1247.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"5516_CR33","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2471\/BLT.16.180273","volume":"95","author":"M O'Leary","year":"2017","unstructured":"O'Leary M, Edmond K, Floyd S, Newton S, Thomas G, Thomas SL. A cohort study of low birth weight and health outcomes in the first year of life, Ghana. Bull World Health Organ. 2017;95(8):574\u201383.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"5516_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/QAI.0b013e3181ffa4f5","volume":"56","author":"KM Powis","year":"2011","unstructured":"Powis KM, Smeaton L, Ogwu A, Lockman S, Dryden-Peterson S, van Widenfelt E, et al. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. J Acquir Immune Defic Syndr. 2011;56(2):131\u20138.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05516-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05516-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05516-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T23:18:06Z","timestamp":1635203886000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05516-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5516"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05516-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"assertion":[{"value":"7 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Zhongnan Hospital affiliated to Wuhan University (ref.200726). All pregnant women provided written informed consent to participate in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"792"}}